Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma × catumaxomab × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 5 Carcinoma, Ovarian Epithelial 4 Peritoneal Neoplasms 3 Fallopian Tube Neoplasms 3 Carcinoma 2 Neoplasms, Glandular and Epithelial 1 Neoplasms 1 Ascites 1 Adenocarcinoma 1

Interventions

pembrolizumab 5 Cisplatin 4 Paclitaxel 3 lenvatinib 2 Fluorouracil 2 trastuzumab deruxtecan 1 sargramostim 1 resiquimod 1 poly ICLC 1 oregovomab 1 liposomal doxorubicin 1 fluoroazomycin arabinoside 1 fludarabine 1 cemiplimab 1 catumaxomab 1 cabozantinib 1 Therapeutics 1 Therapeutic Irrigation 1 TKM-080301 1 Radiation, Ionizing 1 Radiation 1 Proctoscopy 1 Prednisone 1 Prednisolone 1 Papanicolaou Test 1 Oxaliplatin 1 Nelfinavir 1 Metformin 1 MORAb-202 1 Leucovorin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01504256 2018-01-23

CatuNeo

AIO-Studien-gGmbH

Phase 2 Completed

Adenocarcinoma, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡